Abrdn Life Sciences Investors (HQL)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 14.17 |
| Open | 14.26 |
| Bid | 13.53 x 1100 |
| Ask | 14.45 x 1100 |
| Day's range | 14.05 - 14.29 |
| 52-week range | 11.34 - 14.37 |
| Volume | |
| Avg. volume | 85,075 |
| Market cap | 387.557M |
| Beta (5Y monthly) | 0.72 |
| PE ratio (TTM) | 18.01 |
| EPS (TTM) | 0.78 |
| Earnings date | 03 June 2024 - 07 June 2024 |
| Forward dividend & yield | 1.33 (9.39%) |
| Ex-dividend date | 21 Feb 2024 |
| 1y target est | N/A |
- Business Wire
Tekla Funds Approve New Investment Advisory Agreements With abrdn Inc.
BOSTON, October 27, 2023--Tekla Capital Management LLC (Tekla) announced today that the requisite vote has been attained to approve the new investment advisory agreement with abrdn Inc. for each of its four closed-end funds (the Funds).
- Business Wire
Tekla Capital Management LLC Announces Closing of Transaction With abrdn
BOSTON, October 27, 2023--HQH, HQL, THQ, THW
- Business Wire
Tekla Funds Implore Shareholders of THQ and THW to Vote Immediately to Realize Potential Cost Savings for the Funds
BOSTON, October 13, 2023--Tekla Healthcare Investors (HQH) today announced at the Special Meetings of shareholders ("Special Meetings") that the requisite vote had been attained for the proposal to approve the new investment advisory agreement with abrdn Inc.
© 2024 Yahoo. All rights reserved.